EpiPen price increases : how regulatory barriers inhibit pharmaceutical competition : field hearing of the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining EpiPen price increases, focusing on how regulatory barriers inhibit pharmaceutical competition, October 7, 2016 (Lexington, KY).
2018
Y 4.L 11/4:S.HRG.114-805
Linked e-resources
Linked Resource
https://purl.fdlp.gov/GPO/gpo113215
Details
Title
EpiPen price increases : how regulatory barriers inhibit pharmaceutical competition : field hearing of the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining EpiPen price increases, focusing on how regulatory barriers inhibit pharmaceutical competition, October 7, 2016 (Lexington, KY).
Corporate Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Children and Families, author.
Published
Washington : U.S. Government Publishing Office, 2018.
Language
English
Description
iii, 43 pages : illustrations ; 24 cm.
Call Number
Y 4.L 11/4:S.HRG.114-805
GPO Item No.
1043-B (MF)
Note
Shipping list no.: 2019-0162-M.
Bibliography, etc. Note
Includes bibliographical references.
Reproduction
Microfiche. [Washington, D.C.] : U.S. Government Printing Office, [2018] 1 microfiche : negative.
Series
United States. Congress. Senate. S. hrg. ; 114-805.
Available in Other Form
EpiPen price increases
EpiPen price increases
EpiPen price increases
Linked Resources
https://purl.fdlp.gov/GPO/gpo113215
Record Appears in
Online Resources > Government E-Resources
All Resources
All Resources